Intranasal Technology, Inc.
Company announces newly patented lorazepam nasal delivery system
Published in Pharma Law Weekly, January 12th, 2004
The patent entails a complete product concept that includes the route of administration, delivery device, and formulation.
U.S. Patent No. 6,610,271 was issued to a major university with whom ITI contracted to research and develop the lorazepam nasal spray. The patent's inventor is Daniel Wermeling, PharmD, ITI's chief operating officer. ITI holds a worldwide exclusive license to market the lorazepam delivery system and intends to sublicense the product to marketing partners. ITI has filed a continuation-in-part to have other...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2004-01-12)
More Articles from Pharma Law Weekly
- Array BioPharma
Oncology deal signed for development of orally active MEK inhibitor - Oxford Innovation
Oxford's global network boosts healthcare in the Third World - Mayo Clinic
MAPK pathway may be a potential therapeutic target in ALL - Medical University of Lodz
A whole genome screen reveals five genes associated with multiple sclerosis - Medicare
HHS secretary promotes program's changes at Wisconsin town hall meeting - Medicis
FDA approves dermal filler Restylane - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
